Dr. Lisa Carey
Claim this profileUniversity of North Carolina at Chapel Hill
Expert in Breast Cancer
Studies Breast cancer
14 reported clinical trials
27 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 positive
ER positive
2Breast Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Lisa Carey is currently running
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: * Sacituzumab govitecan (Trodelvy™;IMMU-132) * Pembrolizumab (Keytruda®; MK-3475)
Recruiting1 award Phase 215 criteria
Enzalutamide + Mifepristone or Chemotherapy
for Breast Cancer
The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor-positive (AR+) triple negative breast cancer (TNBC) or estrogen receptor-low breast cancer (ER-low BC), and whether these study treatments work as well as standard chemotherapy with carboplatin, paclitaxel, capecitabine, or eribulin.
Recruiting1 award Phase 218 criteria
More about Lisa Carey
Clinical Trial Related3 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Lisa Carey has experience with
- Trastuzumab
- Pertuzumab
- Tucatinib
- Abemaciclib
- Sacituzumab Govitecan
- Pembrolizumab
Breakdown of trials Lisa Carey has run
Breast Cancer
Breast cancer
Endometrial Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lisa Carey specialize in?
Lisa Carey focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Lisa Carey currently recruiting for clinical trials?
Yes, Lisa Carey is currently recruiting for 4 clinical trials in Chapel Hill North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Lisa Carey has studied deeply?
Yes, Lisa Carey has studied treatments such as Trastuzumab, Pertuzumab, Tucatinib.
What is the best way to schedule an appointment with Lisa Carey?
Apply for one of the trials that Lisa Carey is conducting.
What is the office address of Lisa Carey?
The office of Lisa Carey is located at: University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States. This is the address for their practice at the University of North Carolina at Chapel Hill.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.